Henry Schein exits a key Russell index, shares face sector comparison in the S&P 500
29.06.2026 - 12:31:46 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-29, 12:31.
Henry Schein (US42548G1040) has been dropped from the Russell 1000 Dynamic Index while remaining an S&P 500 constituent, according to an index notice compiled by MarketScreener. The dental and medical distributor continues to trade on the Nasdaq, where its shares closed at 84.95 US dollars in recent action.
What the Russell change means
The Russell 1000 Dynamic Index removal highlights a shift in benchmark representation for Henry Schein, which retains exposure through the broader S&P 500 health-care cohort. Such index changes can affect passive flows, as ETF and index fund managers rebalance portfolios against updated constituent lists.
MarketScreener data show Henry Schein’s last close at 84.95 US dollars, with the stock up 1.51 percent on that session. The same compilation cites an average analyst target price of 88.07 US dollars, implying a modest upside versus the latest closing level. Henry Schein remains one of the notable names in US-listed dental and medical supply distribution, alongside peers such as Patterson Companies and Becton Dickinson.
Analyst views after UBS and BTIG moves
The recent index adjustment comes against a backdrop of mixed analyst sentiment on Henry Schein. UBS lowered its price target to 85 US dollars from 87 US dollars in May 2026 and maintained a Neutral rating, signaling a cautious stance on near-term upside. Jefferies also adjusted its target to 80 US dollars from 89 US dollars earlier in May while reiterating a Hold rating, underlining valuation discipline.
In contrast, BTIG upgraded Henry Schein to Buy from Neutral on June 11, 2026, setting a 100 US dollar price target that sits materially above both the current share price and the consensus average. That divergence in targets reflects differing views on how effectively Henry Schein can grow in specialty dental and medical distribution while navigating margin pressures and competition from other large distributors such as McKesson and Cardinal Health. The blend of Neutral and Buy ratings suggests a moderate but not euphoric sentiment across the analyst community.
All news and analysis on the Henry Schein shares
Background reports, price data and further updates on Henry Schein are available for investors who want to follow the stock beyond today’s index and analyst developments.
The business behind the stock
Henry Schein generates revenue primarily by distributing dental, medical and animal health products, along with associated services for professional customers. The group’s portfolio ranges from consumables such as gloves, syringes and dental materials to equipment including imaging systems and chairs, complemented by practice management software and financing solutions.
Where the stock trades today
The Henry Schein shares (US42548G1040) trade on Nasdaq under the ticker HSIC, with the last verified closing price at 84.95 US dollars as of 2026-06-26, 16:00 Eastern time.
Key data on the Henry Schein shares
- Company: Henry Schein, Inc.
- ISIN: US42548G1040
- WKN: 897961
- Ticker: HSIC
- Trading venue: Nasdaq
- Price (as of 2026-06-26, 16:00): 84.95 US dollars
- Market cap: approximately 11.2 billion US dollars (as of late June 2026, based on recent Henry Schein share prices and MarketScreener data).
- Sector / industry: Health Care Equipment & Supplies / Medical Distribution
- Index membership: S&P 500; removed from the Russell 1000 Dynamic Index.
- Next earnings date: not officially scheduled
This article is for information purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on sources deemed reliable but may change over time. Investors should conduct their own research or consult a qualified advisor before making investment decisions.
